breast cancer. Malignant neoplasm: Overlapping lesion of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Study inclusion criteria: 1. Having a wife and sexually active individual reports 2. age between 20 and 50 years 3. Other breast cancer and non-cancer 4. Sexual Distress Scale score above 11 5. fiftieth percentile score means lower sexual behavior of women of reproductive age. 6. treatment of patients with surgery or chemotherapy or both 7. After at least 3 months of treatment, 8. do not receive formal education about sexual issues during the last 6 months 9. no history of mental illness in the past year at least 10. No drugs or alcohol Exclusion criteria Study: 1. relapse 2. intervention during hospitalization 3. Pregnancy 4. Start the field of psychiatric medications 5. participate in therapy sessions over a meeting
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual behavior/ quality of life. Timepoint: befor intervention/ 6 week after intervention/ 12 week after intervention. Method of measurement: DemoDemographic questionnaire, the questions related illness and treatments, native standardized questionnaire and sexual distress, sexual function questionnaire to determine the type of sexual dysfunction, native questionnaire to assess sexual behavior in women of childbearing age and quality of life questionnaire in patients with breast cancer.;Sexual behavior/ quality of life. Timepoint: befor intervention/ 6 week after intervention/ 12 week after intervention. Method of measurement: Demographic questionnaire, the questions related illness and treatments, native standardized questionnaire and sexual distress, sexual function questionnaire to determine the type of sexual dysfunction, native questionnaire to assess sexual behavior in women of childbearing age and quality of life questionnaire in patients with breast cancer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual Fanction. Timepoint: befor intrvention/ 6 week intervention/ 12 week intervention. Method of measurement: Femal sexual function scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Zanjan university medical science